PANDEMIC FLU VACCINE APPROVED FOR CHILDREN - Media Release

The Therapeutic Goods Administration (TGA) has today approved for registration the Australian-made Panvax H1N1 Vaccine Junior enabling children from 6 months to 9 years of age to be protected against the pandemic H1N1 influenza (more)

Back